4000-520-616
欢迎来到免疫在线!(蚂蚁淘生物旗下平台)  请登录 |  免费注册 |  询价篮
主营:主营:分子类,蛋白类,抗体类,生化类试剂
咨询热线电话
4000-520-616
当前位置: 首页 > 产品中心 > peptide > bioporto/Anti-Urokinase plasminogen activator receptor (human, uPAR)/1kit/MON R-4
商品详细bioporto/Anti-Urokinase plasminogen activator receptor (human, uPAR)/1kit/MON R-4
bioporto/Anti-Urokinase plasminogen activator receptor (human, uPAR)/1kit/MON R-4
bioporto/Anti-Urokinase plasminogen activator receptor (human, uPAR)/1kit/MON R-4
商品编号: MONR-4
市场价: ¥0.00
美元价: 0.00
产地: 美国(厂家直采)
公司:
产品分类: 多肽合成
公司分类: peptide
联系Q Q: 3392242852
电话号码: 4000-520-616
电子邮箱: info@ebiomall.com
商品介绍
Cat. No.
MON R-4
Specificity
MON R-4 is specific for human uPAR. No cross-reactivity is observed with murine uPAR, human uPA,human tPA or human PAI-1 when tested by ELISA and immunoblotting. MON R-4 reacts with domain 3when tested by immunoprecipitation of proteolytic fragments of recombinant suPAR.
Immunogen
Native human uPAR
Host
Mouse
Positive Species Reactivity
Human
Negative Species Reactivity
Not determined
Isotype
IgG1
Gene ID
5329
Clone Number
R-4
Epitope Specificity
MON R-4 reacts with an epitope on domain 3
Unit Size
200 µL: Cat. No. MON R-4-021 mL: Cat. No. MON R-4-11 mg/mL +/- 15%. See Certificate of Analysis for details
Purification
Protein A/G purified (from culture supernatant)
Form
Liquid
Solvent
0.01 M phosphate buffer, pH 7.4, with 0.14 M NaCl and 15mM sodium azide
Conjugation
Unconjugated BSA free
Storage
4-8ºC without exposure to light. No precautions necessary during handling.
Target
Urokinase plasminogen activator receptor (uPAR), also known as CD87, is a glycolipid anchored cell surface protein consisting of three homologous domains. It binds uPA with high affinity and enhances and localizes uPA catalyzed plasminogen activation, and thereby plays a key role in cancer invasion and in several tissue remodelling processes. In addition uPAR also binds to vitronectin and may thereby have biological functions independent of its role in uPA mediated proteolysis. Elevated levels of uPAR are associated with poor prognosis in many types of cancer.
Other Info
This product is not for further manufacture.
品牌介绍
  丹麦Bioporto公司成立于2000年,致力于开发抗体产品及诊断试剂盒。2005年首次开发出NGAL ELISA 试剂盒,该产品于2006年获得欧盟CE认证,可用于急性肾功能损伤的临床诊断和监测。其目标是开发出更多的临床诊断专利产品。